Larisa V Gubareva Selected Research

Larisa V Gubareva Research Topics

Disease

70	Human Influenza (Influenza) 01/2022 - 12/2002
34	Infections 01/2022 - 03/2006
8	Influenza in Birds (Avian Flu) 01/2016 - 04/2006
3	Virus Diseases (Viral Diseases) 10/2021 - 02/2012
2	Body Weight (Weight, Body) 12/2016 - 05/2015
2	Weight Loss (Weight Reduction) 04/2014 - 03/2006
1	Hemolysis 04/2014
1	Conjunctivitis 03/2012
1	Herpesviridae Infections (Herpesvirus Infection) 06/2010
1	Orthomyxoviridae Infections 03/2010

Drug/Important Bio-Agent (IBA)

40	Neuraminidase (Sialidase)IBA 01/2022 - 07/2004
34	Oseltamivir (Tamiflu)FDA Link 10/2021 - 03/2006
30	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2009
20	Pharmaceutical PreparationsIBA 10/2021 - 07/2009
11	Zanamivir (Relenza)FDA Link 10/2021 - 03/2008
9	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 12/2002
5	baloxavirIBA 01/2022 - 01/2019
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2006
4	VaccinesIBA 10/2017 - 11/2009
4	oplunofuspIBA 08/2014 - 04/2006
4	AdamantaneIBA 01/2012 - 07/2009
3	EndonucleasesIBA 01/2022 - 01/2019
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2017 - 10/2005
3	peramivirIBA 09/2013 - 08/2006
2	Monoclonal AntibodiesIBA 12/2016 - 01/2011
2	laninamivirIBA 09/2013 - 01/2013
2	Amino Acids FDA Link 04/2011 - 04/2009
2	cyanovirin NIBA 12/2008 - 01/2007
1	AntigensIBA 10/2017
1	AntibodiesIBA 01/2017
1	IsotopesIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016
1	Immune Sera (Antisera)IBA 04/2014
1	NucleotidesIBA 08/2012
1	PolymersIBA 03/2011
1	EnzymesIBA 09/2010
1	favipiravirIBA 06/2010
1	Rimantadine FDA LinkGeneric 03/2010
1	Amantadine (Aman)FDA LinkGeneric 03/2010
1	poly(isobutylene-alt-maleic anhydride)IBA 02/2010
1	Tyrosine (L-Tyrosine)FDA Link 04/2009
1	Histidine (L-Histidine)FDA Link 04/2009
1	Ribavirin (Virazole)FDA LinkGeneric 12/2008
1	PlacebosIBA 12/2008
1	N,N-dodecyl,methyl-polyethylenimineIBA 03/2008
1	methyl inosine monophosphate (MIMP)IBA 08/2006
1	Inosine FDA Link 08/2006
1	Immunologic Factors (Immunomodulators)IBA 08/2006
1	Sialic AcidsIBA 04/2006
1	Recombinant Fusion ProteinsIBA 04/2006
1	sialic acid receptorIBA 04/2006
1	A-322278IBA 03/2006
1	Polysaccharides (Glycans)IBA 10/2005

Therapy/Procedure

7	Therapeutics 12/2016 - 03/2006
2	Chemoprevention 01/2012 - 01/2012
1	Treatment Delay 12/2016
1	Long-Term Care 12/2009
1	Aftercare (After-Treatment) 12/2008